Guggenheim Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-25,987
| Closed | -$1.36M | – | 2166 |
|
|
2020
Q3 | $1.36M | Buy |
+25,987
| New | +$1.08M | 0.01% | 1068 |
|
|
2019
Q2 | – | Sell |
-11,125
| Closed | -$162K | – | 2207 |
|
|
2019
Q1 | $162K | Sell |
11,125
-265
| -2% | -$3.38K | ﹤0.01% | 2105 |
|
|
2018
Q4 | $126K | Sell |
11,390
-28,447
| -71% | -$396K | ﹤0.01% | 2115 |
|
|
2018
Q3 | $1.05M | Buy |
39,837
+5,483
| +16% | +$148K | 0.01% | 1594 |
|
|
2018
Q2 | $702K | Sell |
34,354
-86,245
| -72% | -$1.85M | ﹤0.01% | 1773 |
|
|
2018
Q1 | $2.19M | Buy |
120,599
+6,210
| +5% | +$104K | 0.01% | 1565 |
|
|
2017
Q4 | $1.59M | Buy |
114,389
+68,730
| +151% | +$929K | ﹤0.01% | 1824 |
|
|
2017
Q3 | $847K | Buy |
45,659
+2,920
| +7% | +$48.8K | ﹤0.01% | 2176 |
|
|
2017
Q2 | $721K | Sell |
42,739
-2,272
| -5% | -$34.6K | ﹤0.01% | 2251 |
|
|
2017
Q1 | $602K | Sell |
45,011
-4,889
| -10% | -$76.6K | ﹤0.01% | 2317 |
|
|
2016
Q4 | $751K | Buy |
+49,900
| New | +$659K | ﹤0.01% | 2273 |
|
|
2016
Q2 | – | Sell |
-197,517
| Closed | -$1.82M | – | 2962 |
|
|
2016
Q1 | $1.82M | Sell |
197,517
-22,515
| -10% | -$242K | 0.01% | 1640 |
|
|
2015
Q4 | $3.27M | Buy |
220,032
+123,459
| +128% | +$2.07M | 0.01% | 1273 |
|
|
2015
Q3 | $1.58M | Buy |
+96,573
| New | +$1.98M | ﹤0.01% | 1763 |
|
|
2014
Q4 | – | Sell |
-191,633
| Closed | -$2.17M | – | 3144 |
|
|
2014
Q3 | $2.17M | Buy |
191,633
+22,610
| +13% | +$258K | 0.01% | 1710 |
|
|
2014
Q2 | $2.04M | Sell |
169,023
-30,651
| -15% | -$362K | 0.01% | 1803 |
|
|
2014
Q1 | $2.33M | Buy |
199,674
+41,036
| +26% | +$695K | 0.01% | 1672 |
|
|
2013
Q4 | $2.81M | Buy |
+158,638
| New | +$2.67M | 0.01% | 1488 |
|
Guggenheim Capital's MNTA Position: Q4 2020 in Review
Guggenheim Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 25,987 shares — an estimated $1.36M sold.
Guggenheim Capital first reported a position in MNTA in Q4 2013 and held it in 18 quarters. The position peaked at $3.27M in Q4 2015. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Guggenheim Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Guggenheim Capital sold 25,987 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.36M.
- Guggenheim Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 18 quarters.
- Guggenheim Capital's Momenta Pharmaceuticals, Inc. position peaked at $3.27M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Guggenheim Capital's 13F filing for Q4 2020, filed 16 Feb 2021.